Literature DB >> 19548255

CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches.

Douglas R Langbehn1,2, Michael R Hayden3, Jane S Paulsen1,4.   

Abstract

CAG-repeat length in the gene for HD is inversely correlated with age of onset (AOO). A number of statistical models elucidating the relationship between CAG length and AOO have recently been published. In the present article, we review the published formulae, summarize essential differences in participant sources, statistical methodologies, and predictive results. We argue that unrepresentative sampling and failure to use appropriate survival analysis methodology may have substantially biased much of the literature. We also explain why the survival analysis perspective is necessary if any such model is to undergo prospective validation. We use prospective diagnostic data from the PREDICT-HD longitudinal study of CAG-expanded participants to test conditional predictions derived from two survival models of AOO of HD. A prior model of the relationship of CAG and AOO originally published by Langbehn et al. yields reasonably accurate predictions, while a similar model by Gutierrez and MacDonald substantially overestimates diagnosis risk for all but the highest risk participants in this sample. The Langbehn et al. model appears accurate enough to have substantial utility in various research contexts. We also emphasize remaining caveats, many of which are relevant for any direct application to genetic counseling. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19548255      PMCID: PMC3048807          DOI: 10.1002/ajmg.b.30992

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  33 in total

1.  The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset.

Authors:  J Michael Andresen; Javier Gayán; Luc Djoussé; Simone Roberts; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; James F Gusella; Marcy E MacDonald; Richard H Myers; David E Housman; Nancy S Wexler
Journal:  Ann Hum Genet       Date:  2006-12-19       Impact factor: 1.670

2.  Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.

Authors:  J M Andresen; J Gayán; S S Cherny; D Brocklebank; G Alkorta-Aranburu; E A Addis; L R Cardon; D E Housman; N S Wexler
Journal:  J Med Genet       Date:  2006-10-03       Impact factor: 6.318

3.  Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease.

Authors:  D C Rubinsztein; J Leggo; M Chiano; A Dodge; G Norbury; E Rosser; D Craufurd
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size.

Authors:  R R Brinkman; M M Mezei; J Theilmann; E Almqvist; M R Hayden
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  Preparing for preventive clinical trials: the Predict-HD study.

Authors:  Jane S Paulsen; Michael Hayden; Julie C Stout; Douglas R Langbehn; Elizabeth Aylward; Christopher A Ross; Mark Guttman; Martha Nance; Karl Kieburtz; David Oakes; Ira Shoulson; Elise Kayson; Shannon Johnson; Elizabeth Penziner
Journal:  Arch Neurol       Date:  2006-06

6.  Evidence for the GluR6 gene associated with younger onset age of Huntington's disease.

Authors:  M E MacDonald; J P Vonsattel; J Shrinidhi; N N Couropmitree; L A Cupples; E D Bird; J F Gusella; R H Myers
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

Review 7.  Transcriptional signatures in Huntington's disease.

Authors:  Jang-Ho J Cha
Journal:  Prog Neurobiol       Date:  2007-04-01       Impact factor: 11.685

8.  HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity.

Authors:  Swasti Raychaudhuri; Mithun Sinha; Debashis Mukhopadhyay; Nitai P Bhattacharyya
Journal:  Hum Mol Genet       Date:  2007-10-18       Impact factor: 6.150

9.  Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease.

Authors:  Silke Metzger; Juan Rong; Huu-Phuc Nguyen; Austin Cape; Juergen Tomiuk; Anne S Soehn; Peter Propping; Yun Freudenberg-Hua; Jan Freudenberg; Liang Tong; Shi-Hua Li; Xiao-Jiang Li; Olaf Riess
Journal:  Hum Mol Genet       Date:  2008-01-11       Impact factor: 6.150

10.  Predictors of diagnosis in Huntington disease.

Authors:  Douglas R Langbehn; Jane S Paulsen
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

View more
  132 in total

1.  Challenges assessing clinical endpoints in early Huntington disease.

Authors:  Jane S Paulsen; Chiachi Wang; Kevin Duff; Roger Barker; Martha Nance; Leigh Beglinger; David Moser; Janet K Williams; Sheila Simpson; Douglas Langbehn; Daniel P van Kammen
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

2.  Nonparametric modeling and analysis of association between Huntington's disease onset and CAG repeats.

Authors:  Yanyuan Ma; Yuanjia Wang
Journal:  Stat Med       Date:  2013-09-12       Impact factor: 2.373

Review 3.  The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.

Authors:  Ignacio Munoz-Sanjuan; Gillian P Bates
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

4.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

5.  Tracking motor impairments in the progression of Huntington's disease.

Authors:  Jeffery D Long; Jane S Paulsen; Karen Marder; Ying Zhang; Ji-In Kim; James A Mills
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

6.  Response to Falush: a role for cis-element polymorphisms in HD.

Authors:  Simon C Warby; Henk Visscher; Stefanie Butland; Christopher E Pearson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

7.  Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels.

Authors:  Carlos Cruchaga; Caroline Graff; Huei-Hsin Chiang; Jun Wang; Anthony L Hinrichs; Noah Spiegel; Sarah Bertelsen; Kevin Mayo; Joanne B Norton; John C Morris; Alison Goate
Journal:  Arch Neurol       Date:  2011-01-10

8.  snpXplorer: a web application to explore human SNP-associations and annotate SNP-sets.

Authors:  Niccolo Tesi; Sven van der Lee; Marc Hulsman; Henne Holstege; Marcel J T Reinders
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

9.  Probing the metabolic aberrations underlying mutant huntingtin toxicity in yeast and assessing their degree of preservation in humans and mice.

Authors:  P Matthew Joyner; Ronni M Matheke; Lindsey M Smith; Robert H Cichewicz
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

Review 10.  Presymptomatic ALS genetic counseling and testing: Experience and recommendations.

Authors:  Michael Benatar; Christine Stanislaw; Eliana Reyes; Sumaira Hussain; Anne Cooley; Maria Catalina Fernandez; Danielle D Dauphin; Sara-Claude Michon; Peter M Andersen; Joanne Wuu
Journal:  Neurology       Date:  2016-05-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.